Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals

VRTX

Healthcare
NASDAQ
US

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have…

Power Profile

Revenue Counter

Vertex Pharmaceuticals earns $381.74/sec (TTM: $12.04B)

Revenue counter

Earnings Counter

Vertex Pharmaceuticals earns $125.36/sec net profit (TTM: $3.95B)

Earnings counter

Economic Scale

Vertex Pharmaceuticals revenue exceeds Somalia, Fed. Rep. GDP ($12.0B)

Economic scale

What If Invested

See what $1,000 invested in Vertex Pharmaceuticals would be worth today

What if invested

How it makes money

Visual revenue breakdown: how Vertex Pharmaceuticals generates income and where it flows

How it makes money

Seasonality

Monthly and quarterly returns heatmap, seasonality matrix for Vertex Pharmaceuticals

View seasonality
Q1 2026
Report Date
May 4, 2026
AMC
Lock in
48 days
Revenue
Analyst Forecast
$3.06B
EPS
Analyst Forecast
4.41
Q4 2025
Report Date
Feb 12, 2026
AMC
Lock in
Locked
Revenue
Actual
$3.23B
Analyst Forecast
$3.17B
EPS
Actual
5.03
Analyst Forecast
5.12